Announcements Trials
Browse Landscape

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Conditions

Psoriasis 1Congenital Abnormalities 1Autoimmune Diseases 1Arthritis, Psoriatic 1

Interventions

telitacicept 2Prednisone 2Blood Specimen Collection 2thymoglobulin 1remdesivir 1prednylidene 1fludarabine 1deltacortene 1carmustine, poliferprosan 20 drug combination 1apremilast 1Vitamin D 1Valsartan 1Telemedicine 1Surveys and Questionnaires 1Standard of Care 1Specimen Handling 1Pyridostigmine Bromide 1Practice Guidelines as Topic 1Population Groups 1Peripheral Blood Stem Cell Transplantation 1Nivolumab 1Mycophenolic Acid 1Music Therapy 1Methods 1Melphalan 1Mastectomy, Segmental 1Mammaplasty 1Interviews as Topic 1Infliximab 1Immunotherapy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Autoimmune Diseases × apremilast × Clear all
NCT02775500 2025-01-28

Apremilast Pregnancy Exposure Registry

University of California, San Diego

Active not recruiting
233 enrolled

Congenital Abnormalities, Autoimmune Diseases, Psoriasis, Arthritis, Psoriatic

Data powered by HemOnc (CC BY 4.0) Colophon âš¡